A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis

Clinical trial NCT04176588 · UNKNOWN

Trial details

NCT number: NCT04176588
Sponsor: Everstar Therapeutics Limited
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Moderately to Severely Active Ulcerative Colitis

Start date: 2019-09-10
Primary completion: 2024-07-01
Enrollment: 341

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.